| Net (loss) earnings | -4.05M |
| Depreciation and amortization | 9.86M |
| Deferred income taxes | -3.19M |
| Stock-based compensation expense | 992K |
| Change in fair value of contingent consideration liability | 0 |
| Excess tax benefits from stock-based compensation | -130K |
| Payment for acquisition of business under contingent consideration arrangement | -325K |
| Trade accounts receivable | 6.74M |
| Costs and estimated earnings in excess of billings on long-term contracts | -1.71M |
| Billings in excess of costs and estimated earnings on long-term contracts | -2.3M |
| Inventories | -6.41M |
| Accounts payable | 9.9M |
| Income taxes | 1.6M |
| Accrued compensation and retirement costs | -7.24M |
| Deferred revenue | 1.41M |
| Other | 85K |
| Net cash provided by operating activities in continuing operations | 5.23M |
| Net cash used in operating activities in discontinued operations | 0 |
| Net cash provided by (used in) operating activities | 5.23M |
| Purchases of property, plant and equipment | -5.73M |
| Proceeds from sales of assets | 356K |
| Net cash used in investing activities | -5.37M |
| Net borrowings under revolving credit facility | 13.5M |
| Repayment of other debt | -804K |
| Deferred financing costs paid | 0 |
| Payment for acquisition of business under contingent consideration arrangement | -626K |
| Payments for repurchase and retirement of common shares | -121K |
| Excess tax benefits from stock-based compensation | 130K |
| Proceeds from exercises of stock options | 2.74M |
| Net cash provided by financing activities | 14.82M |
| Effect of changes in exchange rates on cash and cash equivalents | 2.24M |
| Net change in cash and cash equivalents | 16.91M |
| Cash and cash equivalents at beginning of period | 55.94M |
| Cash and cash equivalents at end of period | 72.85M |